(EQS-News / 08/07/2015 / 10:40 UTC+8)

Yestar International Holdings Company Limited
(Stock code：2393.HK)

2015 Interim Results Positive Profit Alert
Consolidated Net Profit Is Expected to Record Not Less Than 55% Growth

[7 July 2015 - Hong Kong] Yestar International Holdings Company Limited ("Yestar International" or the "Company" together with its subsidiaries, the "Group", stock code: 2393.HK) is pleased to announce that based on the preliminary review and assessment of the unaudited consolidated management accounts for the six months ended 30 June 2015, the Group is expected to record a year-on-year increase of not less than 55% in its consolidated net profit. The substantial increase in consolidated net profit is mainly attributable to the significant growth of net profit from the medical consumables products.

Mr. James Hartono, the Chairman of Yestar International, said, "With such strong growth momentum, the medical consumables business has become the largest driving force for the Group's business development. Achieving such outstanding results has fully demonstrated our strong market sense and impeccable execution capability. Through the acquisition of Jiangsu UNO Technology Development Company Limited and the 5 medical equipment and consumable companies namely, Shanghai Emphasis Investment, Shanghai Jianchu Medical, Shanghai Chaolian Trading, Shanghai Haole Industrial and Shanghai Dingpei Industrial, we have successfully established a sizable direct sales and distribution network covering hospitals in Shanghai, Jiangsu Province and Anhui Province. This network serves as a solid foundation for us to explore more collaboration opportunities with global top-tier medical consumable and device brands, whilst diversifying our product offerings. Looking ahead, we will continue to expand our geographical coverage, targeting to build the largest distribution network in China's medical consumables market."

- END -


 
About Yestar International Holdings Company Limited
The Group is one of the fast-growing medical equipment and consumable companies in the PRC, mainly focusing on medical imaging products and IVD products. The Group, also being the manufacturer of medical films for Fujifilm, distributes Roche Diagnostic (Roche) and Becton Dickinson (BD) branded IVD products in Jiangsu and Anhui provinces, the PRC. On 9 April 2015, the Group has entered into a share transfer agreement with an independent third party to acquire the distribution rights and network of Roche and a laboratory equipment brand, Thermo Fisher, in Shanghai. Being the sole processor and exclusive distributor of Fujifilm color photographic papers and industrial imaging products in the PRC, the Group also manufactures and sells dental films under the house brand "Yes!Star".
This press release is issued by DLK Advisory Limited on behalf of Yestar International Holdings Company Limited.

For enquiries, please contact:


DLK Advisory 
E-mail: ir@dlkadvisory.com
Tel:  +852 2857 7101


End of Press Release

+++++


Document: http://n.equitystory.com/c/fncls.ssp?u=EEFJCNLVFK Document title: 2393_Press Release_Eng_20150707

---------------------------------------------------------------------


08/07/2015 UTC+8 Dissemination of a Press Release, transmitted by EQS TodayIR - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Media archive at www.todayir.com

---------------------------------------------------------------------

376105 08/07/2015 UTC+8